A detailed history of Arrowstreet Capital, Limited Partnership transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 206,323 shares of TMO stock, worth $109 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
206,323
Previous 29,949 588.91%
Holding current value
$109 Million
Previous $16.6 Million 670.53%
% of portfolio
0.11%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$531.86 - $624.21 $93.8 Million - $110 Million
176,374 Added 588.91%
206,323 $128 Million
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $14.3 Million - $15.8 Million
26,336 Added 728.92%
29,949 $16.6 Million
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $1.61 Million - $1.83 Million
-3,046 Reduced 45.74%
3,613 $2.1 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $119 Million - $148 Million
-276,900 Reduced 97.65%
6,659 $3.54 Million
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $164 Million - $189 Million
-329,465 Reduced 53.74%
283,559 $144 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $34.9 Million - $40.6 Million
-68,655 Reduced 10.07%
613,024 $320 Million
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $13 Million - $14.7 Million
24,376 Added 3.71%
681,679 $393 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $65.1 Million - $76.7 Million
134,314 Added 25.68%
657,303 $362 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $19.9 Million - $23.7 Million
39,205 Added 8.1%
522,989 $265 Million
Q2 2022

Aug 15, 2022

BUY
$500.9 - $612.21 $33.2 Million - $40.5 Million
66,212 Added 15.86%
483,784 $263 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $147 Million - $180 Million
279,838 Added 203.17%
417,572 $247 Million
Q4 2021

Feb 14, 2022

BUY
$569.0 - $667.24 $74.2 Million - $87 Million
130,459 Added 1793.25%
137,734 $91.9 Million
Q3 2021

Nov 12, 2021

SELL
$509.53 - $609.78 $26.9 Million - $32.2 Million
-52,736 Reduced 87.88%
7,275 $4.16 Million
Q2 2021

Aug 13, 2021

BUY
$441.0 - $508.24 $11.3 Million - $13 Million
25,515 Added 73.97%
60,011 $30.3 Million
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $45.3 Million - $53.4 Million
-102,961 Reduced 74.9%
34,496 $15.7 Million
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $55.1 Million - $66.8 Million
126,582 Added 1163.97%
137,457 $64 Million
Q3 2020

Nov 12, 2020

BUY
$359.77 - $441.52 $3.91 Million - $4.8 Million
10,875 New
10,875 $4.8 Million
Q2 2020

Aug 12, 2020

SELL
$275.2 - $362.34 $22.1 Million - $29.1 Million
-80,260 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$255.3 - $340.05 $17.7 Million - $23.6 Million
-69,437 Reduced 46.39%
80,260 $22.8 Million
Q4 2019

Feb 13, 2020

SELL
$271.93 - $328.04 $16.3 Million - $19.7 Million
-59,983 Reduced 28.61%
149,697 $48.6 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $105 Million - $119 Million
-390,860 Reduced 65.08%
209,680 $61.1 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $69.9 Million - $80.2 Million
-271,298 Reduced 31.12%
600,540 $176 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $13.2 Million - $17 Million
62,144 Added 7.67%
871,838 $239 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $168 Million - $203 Million
806,194 Added 23034.11%
809,694 $181 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $404,972 - $481,310
-1,970 Reduced 36.01%
3,500 $854,000
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $1.11 Million - $1.2 Million
5,470 New
5,470 $1.13 Million
Q1 2018

May 14, 2018

SELL
$192.98 - $224.11 $1.54 Million - $1.79 Million
-7,985 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$182.03 - $200.37 $1.45 Million - $1.6 Million
7,985
7,985 $1.52 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $208B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.